Clinical Trial Detail

NCT ID NCT00194714
Title Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Washington
Indications

breast cancer

ovarian cancer

Therapies

HER2 Vaccine

Age Groups: adult senior

Additional content available in CKB BOOST